Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-31

Clinical Trial Results: Safety and Efficacy of tPBM for Epileptiform Activity in Autism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of transcranial photobiomodulation for epileptiform activity in autism; results completed with posted findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Richard Frye | Conditions: Autism Spectrum Disorder, EEG With Periodic Abnormalities | Phase 2 | Status: COMPLETED | Results posted: 2026-07-31